Basic HTML Version
105
MEMÒRIA CIENTÍFICA 2012
Gracia-Ahufinger I, Fariñas MC, García-Almodovar E, Payeras A, Paño-Pardo JR, Muñez-Rubio
E, Carratalà J; the Novel Influenza A (H1N1) Study Group of the Spanish Network for Research
in Infectious Diseases (REIPI) (Segura F, Navarro G.).
Clin Microbiol Infect
. 2012 Nov;18(11):E485-90.
Analysis of transmitted drug resistance in
Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside
drug class
. Monge S, Guillot V, Alvarez M, Peña A, Viciana P, García-Bujalance S, Pérez
Elias MJ, Iribarren JA, Gutiérrez F, Itziar Casado M, Garcia F; CoRIS (Segura F, Amengual MJ,
Penelo E, Navarro G, Sala M, Cervantes M, Pineda V.).
Clin Microbiol Infect
. 2012 Sep;18(9):894-900.
Impact of changes in CLSI and EUCAST
breakpoints for susceptibility in bloodstream infections due to extended-spectrum ß-
lactamase-producing Escherichia coli
. Rodríguez-Baño J, Picón E, Navarro MD, López-
Cerero L, Pascual A; ESBL-REIPI Group (Navarro G.).
Crit Care
. 2012 Aug 3;16(4):145.
The Barcelona Declaration from the World Alliance
against Antibiotic Resistance: engagement of intensivists
. Carlet JM, Artigas A, Niederman
MS, Torres A; on behalf of World Alliance against Antibiotic Resistance.
Crit Care
. 2012 Nov 18;16(6):R223.
Antibiotic prescription patterns in the empiric therapy
of severe sepsis: combination of antimicrobials with different mechanisms of action
reduces mortality
. Díaz-Martín A, Martínez-González ML, Ferrer R, Ortiz-Leyba C, Piacentini
E, Lopez-Pueyo MJ, Martín-Loeches I, Levy MM, Artigas A, Garnacho-Montero J; for the
Edusepsis Study Group.
Curr HIV Res
. 2012 Dec 1;10(8):673-8.
Switching to Raltegravir in Virologically Suppressed
in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study
. Podzamczer
D, Martínez E, Domingo P, Ferrer E, Viciana P, Curto J, Pérez-Elías MJ, Ocampo A, Santos I,
Knobel H, Estrada V, Negredo E, Segura F, Portilla J, Ribera E, Galindo J, Antela A, Carmena
J, Castaño M, The Toral Study Group.
Enferm Infecc Microbiol Clin
. 2012 Jun;30 Suppl 3:33-8.
Device-associated infection rates in
Adult Intensive Care Units in Catalonia: VINCat Program findings
. Vallès J, Limón E, Díaz
E, Fernández I, Palomar M, Barcenilla F, Alvarez-Lerma F, Pujol M; VINCat Program.
Enferm Infecc Microbiol Clin
. 2012 Jun;30 Suppl 3:43-51.
Antibiotic consumption at 46
VINCat hospitals from 2007 to 2009, stratified by hospital size and clinical services
. Grau
S, Fondevilla E, Mojal S, Palomar M, Vallès J, Gudiol F; VINCat Antimicrobial Group.
Enferm Infecc Microbiol Clin
. 2012 Nov;30(9):517-27.
[Cardiovascular risk in human
immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011]
. Masiá M, Pérez-
Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, Blanco JR, Peña A, Rodríguez
F, Vera M, Del Amo J, Gutiérrez F; Grupo de estudio de riesgo cardiovascular de CoRIS
(Navarro G.).